516 results
-
List item
Withdrawn application: Pioglitazone ratiopharm
pioglitazone, date of withdrawal: 03/02/2012, Initial authorisation, Last updated: 30/04/2012Pioglitazone ratiopharm: Withdrawn application … Pioglitazone ratiopharm: Withdrawal of the marketing … authorisation) Pioglitazone ratiopharm pioglitazone On 21 July … -
List item
Withdrawn application: Pioglitazone ratiopharm GmbH
pioglitazone, date of withdrawal: 03/02/2012, Initial authorisation, Last updated: 30/04/2012Pioglitazone ratiopharm GmbH: Withdrawn application … Pioglitazone ratiopharm GmbH: Withdrawal of the marketing … authorisation) Pioglitazone ratiopharm GmbH pioglitazone On 21 … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam ratiopharm
levetiracetam, Epilepsy
Date of authorisation: 26/08/2011,
, Revision: 14, Authorised, Last updated: 10/06/2022
Levetiracetam ratiopharm Nervous System Diseases Central … EPAR) for Levetiracetam ratiopharm. It explains how the Committee … of use for Levetiracetam ratiopharm. What is Levetiracetam ratiopharm and what is it used for … -
List item
Human medicine European public assessment report (EPAR): Sildenafil ratiopharm
sildenafil, Erectile Dysfunction
Date of authorisation: 23/12/2009,, Revision: 19, Authorised, Last updated: 24/06/2022
Sildenafil ratiopharm Male Urogenital Diseases Genital … sildenafil. What is Sildenafil ratiopharm? Sildenafil ratiopharm is a medicine that contains … 50 and 100 mg). Sildenafil ratiopharm is a ‘ A generic medicine … -
List item
Human medicine European public assessment report (EPAR): Leflunomide ratiopharm
leflunomide, Arthritis, Rheumatoid
Date of authorisation: 28/11/2010,, Revision: 16, Authorised, Last updated: 17/05/2022
Leflunomide ratiopharm Musculoskeletal Diseases Joint … Leflunomide ratiopharm … the public Leflunomide ratiopharm leflunomide This is a … -
List item
Human medicine European public assessment report (EPAR): Desloratadine ratiopharm
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 13/01/2012,, Revision: 12, Authorised, Last updated: 24/06/2022
Desloratadine ratiopharm Respiratory Tract Diseases Nose … desloratadine Overview Desloratadine ratiopharm is a medicine used in adults … is unknown. Desloratadine ratiopharm contains the active substance … -
List item
Human medicine European public assessment report (EPAR): Rasagiline ratiopharm
rasagiline, Parkinson Disease
Date of authorisation: 12/01/2015, Revision: 8, Authorised, Last updated: 05/11/2021Rasagiline ratiopharm Nervous System Diseases Central … Rasagiline ratiopharm … for the public Rasagiline ratiopharm rasagiline This is a summary … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm
clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 5, Withdrawn, Last updated: 12/12/2013
Clopidogrel ratiopharm Peripheral Vascular Diseases Stroke Myocardial … authorisation for Clopidogrel ratiopharm has been withdrawn at the … Summary documents Clopidogrel ratiopharm : EPAR - Summary for the … -
List item
Human medicine European public assessment report (EPAR): Filgrastim ratiopharm
filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 15/09/2008,
, Revision: 1, Withdrawn, Last updated: 20/07/2011
Filgrastim ratiopharm Neutropenia Hematopoietic … Filgrastim ratiopharm … Filgrastim ratiopharm, INN-filgrastim 7 Westferry … -
List item
Human medicine European public assessment report (EPAR): Memantine ratiopharm
memantine hydrochloride, Alzheimer Disease
Date of authorisation: 12/06/2013,, Revision: 8, Authorised, Last updated: 30/06/2022
Memantine ratiopharm Nervous System Diseases Central … report (EPAR) for Memantine ratiopharm. It explains how the European … advice on how to use Memantine ratiopharm. For practical information … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm GmbH
clopidogrel, Peripheral Vascular Diseases; Acute Coronary Syndrome; Myocardial Infarction; Stroke
Date of authorisation: 28/07/2009,, Revision: 12, Withdrawn, Last updated: 25/01/2021
Clopidogrel ratiopharm GmbH Peripheral Vascular … authorisation for Clopidogrel Ratiopharm GmbH has been withdrawn at … Summary documents Clopidogrel ratiopharm GmbH : EPAR - Summary for … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm
clopidogrel (as hydrogen sulfate), Myocardial Infarction; Acute Coronary Syndrome; Peripheral Vascular Diseases; Stroke
Date of authorisation: 18/02/2015,, Revision: 14, Authorised, Last updated: 15/11/2022
Clopidogrel ratiopharm Cardiovascular Diseases Vascular … report (EPAR) for Clopidogrel ratiopharm. It explains how the Agency … on how to use Clopidogrel ratiopharm. For practical information … -
List item
Referral: Vasotop P
ramipril, Article 13
Status: European Commission final decision, opinion/position date: 08/12/2009, EC decision date: 27/04/2010, Last updated: 14/08/2014contain the active ingredient ramipril at concentrations of 0.625 … and 2.5 mg respectively. Ramipril is an angiotensin-converting … to assess the efficacy of ramipril in cats to reduce systolic … -
List item
Referral: Tritace
ramipril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 06/03/2009, Last updated: 24/04/2009active substance in Tritace, ramipril, is an angiotensin-converting … Protect Startset, Delix P, Ramipril Winthrop Ramipril Prevent, Loavel, Ramiwin Ramipril Medgenerics, Ramilich, Tritace … hard capsules containing ramipril 1.25 mg, 2.5 mg, 5 mg and … -
List item
Orphan designation: Ramiprilat for: Treatment of Stargardt's disease
Date of designation: 12/03/2013, Positive, Last updated: 17/01/2023Ramiprilat Overview On 12 March 2013 … Iris Pharma, France, for ramiprilat for the treatment of Stargardt's … medicine expected to work? Ramiprilat is an angiotensin-converting-enzyme … -
List item
Referral: Tritazide
ramipril, hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 06/03/2009, Last updated: 14/04/2009contains two active substances, ramipril and hydrochlorothiazide Ramipril is an angiotensin converting … adequately controlled with ramipril alone or hydrochlorothiazide … Tritace HCT, Triatec HCT, Ramipril e Idrocloritiazide, Ramicor … -
List item
Referral: Rambis and associated names (updated)
ramipril, bisoprolol fumarate, associated names: Ralbior, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/12/2022, EC decision date: 15/02/2023, Last updated: 08/03/2023authorisation of Rambis (ramipril / bisoprolol) in the EU On … combination of two medicines called ramipril and bisoprolol. Rambis contains … bisoprolol. Rambis contains both ramipril and bisoprolol and is intended … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Ramipril, indapamide
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-002081-PIP01-16, Route(s) of administration: Oral use, Pharmaceutical form(s): Modified-release tablet
Decision date: 05/05/2017, Last updated: 04/07/2017, Compliance check: XKey facts Ramipril indapamide Cardiovascular … product-specific waiver for ramipril / indapamide (EMEA-002081-PIP01-16 … product specific waiver for ramipril / indapamide (EMEA-002081-PIP01-16 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Ramipril, amlodipine
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-001871-PIP01-15, Route(s) of administration: Oral use, Pharmaceutical form(s): Capsule, hard
Decision date: 04/02/2016, Last updated: 22/04/2016, Compliance check: XKey facts Ramipril amlodipine Cardiovascular … product specific waiver for ramipril / amlodipine (EMEA-001871-PIP01-15 … product specific waiver for ramipril / amlodipine (EMEA-001871-PIP01-15 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): amlodipine, Ramipril
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: P/0323/2014, Route(s) of administration: Oral use, Pharmaceutical form(s): Capsule, hard
Decision date: 19/12/2014, Last updated: 23/02/2015, Compliance check: XKey facts amlodipine Ramipril Cardiovascular diseasesP/0323/2014P/0323/2014 … specific waiver for amlodipine / ramipril (EMEA-001685-PIP01-14) PDF … product-specific waiver: Amlodipine / ramipril for treatment of hypertension … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): amlodipine, Ramipril
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-001464-PIP01-13, Route(s) of administration: Oral use, Pharmaceutical form(s): Capsule, hard
Decision date: 30/07/2013, Last updated: 03/09/2013, Compliance check: XKey facts amlodipine Ramipril Cardiovascular diseasesP/0180/2013EMEA-001464-PIP01-13 … product-specific waiver for amlodipine / ramipril (EMEA-001464-PIP01-13) PDF … specific waiver for amlodipine / ramipril (EMEA-001464-PIP01-13) in … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): amlodipine, Ramipril
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-000887-PIP01-10, Route(s) of administration: Oral use, Pharmaceutical form(s): Capsule, hard
Decision date: 28/07/2010, Last updated: 26/08/2010, Compliance check: XKey facts amlodipine Ramipril Cardiovascular diseasesP/136/2010EMEA-000887-PIP01-10 … specific waiver for amlodipine/ramipril (EMEA-000887-PIP01-10) in … specific waiver for amlodipine/ramipril (EMEA-000887-PIP01-10) in … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): telmisartan, Ramipril
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-000045-PIP01-07, Route(s) of administration: Oral use, Pharmaceutical form(s): Tablet
Decision date: 01/02/2008, Last updated: 15/02/2008, Compliance check: XActive substance telmisartan Ramipril Therapeutic area Cardiovascular … substance: Telmisartan / ramipril (fixed combination) Condition(s … telmisartan Ramipril … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Rosuvastatin, Ramipril
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-002569-PIP04-19, Route(s) of administration: Oral use, Pharmaceutical form(s): Capsule, hard
Decision date: 11/09/2020, Last updated: 25/03/2020, Compliance check: XKey facts Rosuvastatin Ramipril Cardiovascular diseasesP/0343/2019EMEA-002569-PIP04-19 … waiver for rosuvastatin / ramipril (EMEA-002569-PIP01-19) PDF … Rosuvastatin Ramipril … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Rosuvastatin, Ramipril
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-002569-PIP04-19, Route(s) of administration: Oral use, Pharmaceutical form(s): Capsule, hard
Decision date: 11/09/2020, Last updated: 25/03/2020, Compliance check: XKey facts Rosuvastatin Ramipril Cardiovascular diseasesP/0343/2019EMEA-002569-PIP04-19 … waiver for rosuvastatin / ramipril (EMEA-002569-PIP01-19) PDF … Rosuvastatin Ramipril …